Celestra Inc.
Founded in 2011 and KOSDAQ-listed in 2020, Celestra develops genome-based liquid biopsy and early cancer diagnostic technologies.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2011 and listed on KOSDAQ in 2020, Celestra is a genome-based liquid biopsy and early cancer diagnostics company. It sells the CD-Prime (OPR1,000/OPR2,000) liquid biopsy platform, which simultaneously detects CTC and cfDNA from blood, more than ten genomic diagnostic tests including Geno-D, Geno-Dx, and Geno-Cancer, and cancer mutation diagnostic/monitoring products such as Cancer-Prime and Cancer-Panel. It licensed in 15 patents related to CD-PRIME from UNIST under an exclusive license (2015-2025), licensed out its Dognomics technology to Pyrico Inc. for KRW 100 million (2023-2026), and transferred RT-PCR reagent technology to AI Biotics Inc. (2022-2027, KRW 5 million upfront).
Products & technology
- CD-Prime (OPR1,000/OPR2,000)Liquid biopsy simultaneously detecting CTC and cfDNA from blood
- Genomic diagnostic tests (Geno-D, Geno-Dx, Geno-Cancer, and others, 10+ products)Genomic testing to predict physical traits and disease risk
- Cancer-Prime, Cancer-PanelCancer mutation diagnosis and monitoring
- Multi-omics based early cancer diagnostics (Cardiomics, Stressomics, etc.)Early diagnosis of major diseases including colorectal and lung cancer
R&D and key agreements
Source: DART corporate disclosure다중오믹스 기반 조기진단(Cardiomics, Stressomics 등) · 대장암, 폐암 등 · 개발중 · Developing multi-omics (genomic and epigenomic) based early diagnostic services for major diseases including colorectal and lung cancer
Companies in the same categoryMedical Devices
Founded 2009, listed on KOSDAQ in 2019, JETEMA develops hyaluronic acid fillers, botulinum toxin biopharmaceuticals, and lifting threads.
Founded in 2000 and KOSDAQ-listed in 2013, i-SENS makes blood glucose monitors and point-of-care testing devices.
Founded in 2010 and KOSDAQ-listed in 2018, Sejong Medical manufactures laparoscopic surgical instruments.
Founded in 1987 and listed on KOSDAQ in 2000, NanoenTek develops Lab-On-a-Chip in-vitro diagnostic devices and life science instruments.
Founded in 2015 and listed on KOSDAQ in 2022, Noul develops the on-device AI diagnostic platform miLab™ for blood and cancer testing.
KOSDAQ-listed manufacturer of diagnostic X-ray imaging systems and core components such as generators and tubes.
KOSDAQ-listed molecular genetic diagnostics company providing NGS-based non-invasive prenatal testing (NIPT) under the MomGuard brand.
Founded in 2000 and KOSDAQ-listed in 2013, Corentec makes artificial joints; hip and knee implants exceed 85% of revenue.
Established in 2012 and listed on KOSDAQ in 2018, Osteonic manufactures implants for the CMF, Trauma, Sports Medicine, and Spine categories.
Founded 2010, listed on KOSDAQ in 2021, Genesystem develops molecular diagnostic systems, biochips, test kits, and reaction reagents.
Founded in 1961 and KOSPI-listed in 1976, SBSUNGBO makes and sells crop protection agents (fungicides, insecticides, herbicides).
Founded in 2000 and KOSDAQ-listed in 2010, Seegene develops syndromic multiplex PCR molecular diagnostic reagents.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition